Cenra Inc. (TPE:3716)

Taiwan · Delayed Price · Currency is TWD

34.00

-0.75 (-2.16%)

At close: Aug 18, 2026

-1.16% (1Y)

Market Cap	4.97B -1.1%
Revenue (ttm)	8.54B -3.9%
Net Income	377.97M +14.7%
EPS	3.01 +11.8%
Shares Out	146.14M
PE Ratio	11.29
Forward PE	n/a
Dividend	1.00 (2.95%)
Ex-Dividend Date	Jul 23, 2026

Volume	777,542
Open	34.70
Previous Close	34.75
Day's Range	33.80 - 34.70
52-Week Range	31.55 - 36.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 19, 2026

About Cenra

Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. It provides CDMO services for internal and external partners; oral solids, injectables, specialty formulations, and APIs, supported by process development, scale-up, and regulatory support; oral solids, injectables, specialty formulations, and high-purity active pharmaceutical ingredients (APIs), supported by process development, scale-up, and regulatory support; distribution, and marketing for pres... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 2024

Employees 542

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 3716

Full Company Profile

Financial Performance

In 2025, Cenra's revenue was 8.57 billion, a decrease of -3.91% compared to the previous year's 8.92 billion. Earnings were 300.07 million, a decrease of -5.44%.

Financial Statements